HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vassiliki Aroniadou-Anderjaska Selected Research

caramiphen

11/2020Electroencephalographic analysis in soman-exposed 21-day-old rats and the effects of midazolam or LY293558 with caramiphen.
10/2018Full Protection Against Soman-Induced Seizures and Brain Damage by LY293558 and Caramiphen Combination Treatment in Adult Rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Vassiliki Aroniadou-Anderjaska Research Topics

Disease

17Status Epilepticus (Complex Partial Status Epilepticus)
12/2020 - 02/2008
17Seizures (Absence Seizure)
11/2020 - 08/2009
3Mental Disorders (Mental Disorder)
02/2014 - 10/2004
3Epilepsy (Aura)
02/2011 - 02/2008
2Body Weight (Weight, Body)
10/2018 - 11/2017
1Atrophy
01/2018
1Anxiety Disorders (Anxiety Disorder)
09/2014
1Schizophrenia (Dementia Praecox)
11/2013
1Alzheimer Disease (Alzheimer's Disease)
11/2013
1Respiratory Insufficiency (Respiratory Failure)
01/2013
1Pain (Aches)
02/2011
1Traumatic Brain Injuries (Traumatic Brain Injury)
02/2008
1Stroke (Strokes)
02/2008
1Temporal Lobe Epilepsy
02/2008

Drug/Important Bio-Agent (IBA)

17Nerve AgentsIBA
12/2020 - 09/2009
12SomanIBA
11/2020 - 09/2010
8tezampanelIBA
11/2020 - 02/2011
6Diazepam (Valium)FDA LinkGeneric
12/2020 - 01/2010
6Anticonvulsants (Antiepileptic Drugs)IBA
12/2020 - 08/2009
5AcetylcholinesteraseIBA
01/2020 - 09/2013
3Midazolam (Versed)FDA LinkGeneric
12/2020 - 01/2020
3Kainic Acid Receptors (Kainate Receptor)IBA
11/2014 - 10/2004
3AcidsIBA
01/2013 - 08/2009
2BenzodiazepinesIBA
12/2020 - 01/2018
2alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA
11/2020 - 02/2011
2caramiphenIBA
11/2020 - 10/2018
2OrganophosphatesIBA
01/2020 - 01/2017
2Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
01/2020 - 01/2017
2AtropineFDA LinkGeneric
04/2015 - 01/2013
21H-tetrazole (tetrazole)IBA
01/2013 - 02/2011
2Carboxylic AcidsIBA
01/2013 - 02/2011
2GABA-A Receptors (GABA(A) Receptor)IBA
03/2011 - 01/2010
1Neuroprotective AgentsIBA
12/2020
1Muscarinic AntagonistsIBA
11/2020
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
11/2020
1Acetylcholine (Acetylcholine Chloride)FDA Link
01/2020
1N- (3- oxo- 3- (4- (pyridin- 4- yl)piperazin- 1- yl)propyl)benzo(c)(1,2,5)thiadiazole- 4- sulfonamideIBA
01/2017
1Muscarinic M1 ReceptorIBA
01/2017
11- (2- amino- 2- carboxyethyl)- 3- (2- carboxybenzyl)pyrimidine- 2,4- dioneIBA
11/2014
1willardiineIBA
11/2014
1Cholinergic Agents (Cholinergics)IBA
09/2014
1Acid Sensing Ion ChannelsIBA
02/2014
1NicotineFDA Link
11/2013
1Anti-Anxiety Agents (Anxiolytics)IBA
11/2013
1OximesIBA
01/2013
1AMPA Receptors (AMPA Receptor)IBA
01/2013
1asoxime chloride (H16)IBA
01/2013
1ConvulsantsIBA
03/2011
1cyclonite (RDX)IBA
03/2011
1Kainic Acid (Kainate)IBA
02/2011
1fluoro-jade CIBA
09/2010
1Gluk1 kainate receptorIBA
08/2009
1Topiramate (Topamax)FDA LinkGeneric
08/2009
1sulfamic acid (ammonium sulfamate)IBA
08/2009

Therapy/Procedure

1Emergency Treatment
02/2011
1Drug Therapy (Chemotherapy)
02/2008